Combined together, these studies provide significant insights into the role of TGF-β signaling in suppressing adipose browning program within white fat tissues in both mouse models and human subjects, suggesting that blockade of TGF-β activity could serve as an effective treatment strategy for obesity and diabetes. Here, TGFB1 is linked to obesity disorder.